Shivalik Rasayan Limited manufactures specialty chemicals and pharmaceutical-related products, including chemicals used in industrial and healthcare applications. Its business benefits from demand for specialty chemicals and pharmaceutical intermediates. Capacity expansion and product diversification provide opportunities. Raw-material prices, environmental regulations, energy costs, capacity utilization and competition remain important factors.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROE previous year | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹514 cr | ₹375 cr | ₹20 cr | 37.6 | 8.67 | 0.86 | 2.1% | 3.2% | 4.6% | 0.19 | ₹-57 cr | 12.4 | 1.10 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 96 | 4 | 2.16 | +111.8% | +7.9% | 4.7% |
| Mar 2026 | 103 | 7 | 2.87 | +9.5% | +48.2% | 7.0% |
| Dec 2025 | 82 | 4 | 1.71 | -49.6% | -3.8% | 4.5% |
| Sep 2025 | 94 | 4 | 1.93 | -25.2% | +13.8% | 4.6% |
| Jun 2025 | 89 | 3 | 1.02 | -55.1% | +19.7% | 3.2% |
| Mar 2025 | 69 | 5 | 2.62 | +15.9% | -2.6% | 7.5% |
| Dec 2024 | 85 | 7 | 3.39 | +67.0% | +21.5% | 8.1% |
| Sep 2024 | 82 | 4 | 2.58 | +104.8% | +23.0% | 5.4% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✓ Pass |
| EPS growth accelerating over 3 quarters | ✓ Pass |
| Sales up 25%+, or sales growth accelerating | ✗ Fail |
| Annual EPS up 25%+ in each of the last 2 years | ✗ Fail |
| Net margin above the same quarter last year | ✓ Pass |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✓ At least 25% above the 52-week low · low 209.50 ✗ Within 25% of the 52-week high · high 462.35 ✓ RS percentile 70 or more · RS 80 Trend template - the gate, measured: a modest 21-day edge. | 4/8 | 4 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 2 - advancing | |
| CAN SLIM | ✓ C latest quarter EPS up 25%+ ✗ A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 462.35 ✓ S more volume on up days than down days (50 sessions) · 1.35x ✓ L RS percentile 80 or more · RS 80 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 4/6 | Average |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 436.90 ✗ Close above the prior 20-session high · 436.90 ✓ Close below the prior 20-session low · 339.00 Donchian channel breakout - the Turtle traders' entry. | Breakdown | |
| Greenblatt | — Earnings yield (EBITDA / EV) · 8.1% — Return on capital (ROCE) · 4.6% Joel Greenblatt's Magic Formula: good businesses at good prices, ranked across all companies. Earnings yield uses EBITDA, as EBIT is not held separately. | 24/100 | Weak |
| Graham | ✗ Price at or below the Graham number · Graham number 272.06 ✗ P/E 15 or less · P/E 37.6 ✓ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 0.86 ✓ Current ratio 2 or more · 2.01 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 83/100 | Fair |
| Piotroski | ✓ Profitable (ROA > 0) ✗ Operating cash flow positive ✗ ROA rising ✗ Cash flow above net profit (earnings quality) ✗ Long-term debt / assets falling ✓ Current ratio rising · 2.01 ✓ No new shares issued ✗ Margin rising (net margin) ✓ Asset turnover rising Joseph Piotroski's F-score, FY 2025 -> 2026. | 4/9 | Weak |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SHIVALIK this stock | -12.3 | +48.5 | +20.4 | -20.0 | -53.5 | — | 37.6 | 0.86 | 2.1 | 4.6 | — | 0.19 | 12.4 | 514 | 375 | 20 | 8.7 | 1.10 |
| MODISONLTD | +3.6 | +60.2 | +224.7 | +204.5 | +480.5 | — | 13.6 | 4.78 | 29.5 | 28.6 | — | 0.69 | 10.5 | 1,539 | 980 | 113 | 34.9 | 1.14 |
| SBCL | -8.8 | +33.9 | +91.9 | +110.0 | +82.4 | +415.3 | 54.3 | 11.97 | 21.6 | 26.2 | — | 0.12 | 41.9 | 5,760 | 616 | 106 | 18.4 | 1.23 |
| MARINE | +14.0 | +69.8 | +108.9 | +89.0 | +457.8 | +1158.5 | 93.8 | 12.27 | 13.0 | 18.2 | — | 0.17 | 55.4 | 6,050 | 969 | 64 | 4.6 | 1.56 |
| APARINDS | -16.6 | +13.3 | +31.4 | +81.1 | +196.6 | +2119.6 | 54.6 | 11.72 | 19.7 | 31.2 | — | 0.16 | 33.8 | 63,216 | — | — | 293.4 | 1.17 |
| RISHABH | -9.6 | +5.2 | +44.8 | +80.7 | +33.1 | — | 26.4 | 3.59 | 12.0 | 14.5 | — | 0.10 | 17.9 | 2,673 | 973 | 102 | 26.1 | 1.46 |
| DENORA | -9.2 | -19.4 | -12.3 | -8.4 | -56.9 | +105.5 | 30.9 | 2.92 | 7.3 | 9.6 | — | 0.00 | 25.2 | 377 | 115 | 12 | 23.0 | 1.05 |
| BBL | +9.6 | -9.6 | -14.4 | -22.1 | +26.8 | +246.8 | 24.5 | 1.35 | 6.1 | 8.2 | — | 0.15 | 15.3 | 2,734 | 2,356 | 112 | 99.0 | 0.80 |
| ELECTHERM | -28.5 | -38.0 | -12.5 | -33.5 | +394.9 | +399.4 | — | — | 10.0 | 0.1 | — | -6.89 | 43.3 | 843 | 3,771 | -36 | -28.6 | 1.39 |
| SALZERELEC | -11.3 | -16.9 | -22.3 | -41.6 | +21.0 | +202.0 | 19.8 | 1.46 | 9.3 | 11.5 | — | 0.90 | 9.5 | 864 | 1,815 | 45 | 24.7 | 1.35 |
| HPL | -10.6 | -25.4 | -29.9 | -42.6 | +20.6 | +268.5 | 17.9 | 1.63 | 9.5 | 13.2 | — | 0.75 | 8.5 | 1,635 | 1,943 | 92 | 14.2 | 1.71 |